Affibody And UCB Eye Humira’s Weak Spot In Hidradenitis Suppurativa

Following Positive R&D Milestones

 
• By Ayisha Sharma
  
New Biologic Candidates For HS Could Challenge AbbVie's Humira • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D